ArticleCancer medicine2021

Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models.

Wei-Pang Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.